Tag: Dentistry

  • Chronic pain, metal jaws, and futile treatments

    Chronic pain, metal jaws, and futile treatments

    [ad_1]

    A TMJ patient in Maine had six surgeries to replace part or all of the joints of her jaw.

    Another woman in California, desperate for relief, used a screwdriver to lengthen her jawbone daily, turning screws that protruded from her neck.

    A third in New York had bone from her rib and fat from her belly grafted into her jaw joint, and twice a prosthetic eyeball was surgically inserted into the joint as a placeholder in the months it took to make metal hinges to implant into her jaw.

    “I feel like Mr. Potato Head,” said Jenny Feldman, 50, of New York City, whose medical records show she’s had at least 24 TMJ-related surgeries since she was a teenager. “They’re moving ribs into my face, and eyeballs, and I feel like a toy … put together [by] somebody just tinkering around.”

    These are some of the horrors of temporomandibular joint disorders, known as TMJ or TMD, which afflict up to 33 million Americans, according to the National Institutes of Health. Dentists have attempted to heal TMJ patients for close to a century, and yet the disorders remain misunderstood, under-researched, and ineffectively treated, according to an investigation by KFF Health News and CBS News.

    Dental care for TMJ can do patients more harm than good, and a few fall into a spiral of futile surgeries that may culminate in their jaw joints being replaced with metal hinges, according to medical and dental experts, patients, and their advocates speaking in interviews and video testimony submitted to the FDA.

    TMJ disorders cause pain and stiffness in the jaw and face that can range from discomfort to disabling, with severe symptoms far more common in women. Dentists have commonly treated the disorder with splints and orthodontics. And yet these treatments are based on “strongly held beliefs” and “inadequate research” — not compelling scientific evidence nor consistent results — according to the National Academies of Sciences, Engineering and Medicine, which reviewed decades of research on the topic. The NIH echoes this message, warning that there is “not a lot of evidence” that splints reduce pain and recommends “staying away” from any treatment that permanently changes the teeth, bite, or jaw.

    “I would say that the treatments overall have not been effective, and I can understand why,” said Rena D’Souza, director of the NIH’s National Institute of Dental and Craniofacial Research. “We don’t understand the disease.”

    For this investigation, journalists with KFF Health News and CBS News interviewed 10 TMJ patients with severe symptoms who said they felt trapped by an escalating series of treatments that began with splints or dental work and grew into multiple surgeries with diminishing returns and dwindling hope.

    In every interview, the patients said the TMJ pain worsened throughout their treatment and they regretted some, if not all, of the care they received.

    “The grand irony to me is that I went to the doctor for headaches and neck pain, and I’ve had 13 surgeries on my face and jaw, and I still have even worse neck pain,” said Tricia Kalinowski, 63, of Old Orchard Beach, Maine. “And I live with headaches and jaw pain every day.”

    TMJ has become an umbrella term for about 30 disorders that afflict roughly 5% to 10% of Americans. Minor symptoms may not require treatment at all, and many cases resolve by themselves over time. Severe symptoms include chronic pain and may limit the ability to eat, sleep, or talk.

    In a comprehensive study of TMJ disorders by the national academies, including input from more than 110 patients, experts found that most health care professionals, including dentists, have received “minimal or no training” on TMJ disorders and patients are “often harmed” by “overly aggressive” care and the lack of proven treatments.

    Almost 100 years this has been in dentistry, and look at what we have… A whole ton of people pretending they know everything, and we don’t know anything.”


    Terrie Cowley, TMJ patient

    The American Dental Association, which represents about 160,000 dentists nationwide and establishes guidelines for the profession, declined an interview request. In a written statement, ADA President Linda Edgar said that TMJ disorders are “often managed rather than cured” and that it sees “great potential” in new efforts to research more treatment options.

    Terrie Cowley, a longtime TMJ patient who leads the TMJ Association, an advocacy group that has spoken with tens of thousands of patients, said she was so disillusioned with dental care for TMJ that she advises many patients to avoid treatment entirely, potentially for years.

    “Almost 100 years this has been in dentistry, and look at what we have,” Cowley said. “A whole ton of people pretending they know everything, and we don’t know anything.”

    ‘Not taken seriously’

    Scientific studies have found that TMJ disorders arise up to nine times as often in women, particularly those in their 20s and 30s, leading to theories that the cause may be linked to reproductive hormones. But a true understanding of TMJ disorders remains elusive.

    Kyriacos Athanasiou, a biomedical engineering professor at the University of California-Irvine, said it was because TMJ disorders are more prevalent among women that they were historically dismissed as neither serious nor complex, slowing research into the cause and treatment.

    The resulting dearth of knowledge, which is glaring when compared with other joints, has been “a huge disservice” to patients, Athanasiou said. In a 2021 study he co-authored, researchers found that the knee, despite being a much simpler joint, was the subject of about six times as many research papers and grants in a single year than the jaw joint.

    D’Souza agreed that TMJ disorders were “not taken seriously” for decades, along with other conditions that predominantly affect women.

    “That has been a bias that is really long-standing,” she said. “And it’s certainly affected the progress of research.”

    Patients have felt the effect too. In interviews, female patients said they felt patronized or trivialized by male health care providers at some point in their TMJ treatment, if not throughout. Some said they felt blamed for their own pain because they were viewed as too stressed and clenching their jaw too much.

    “We desperately need research to find the reasons why more women get TMJ disease,” wrote Lisa Schmidt, a TMJ Association board member, in a 2021 newsletter from the organization. “And surgeons need to stop blaming this condition on women.”

    Every time you have a surgery, your pain gets worse… If I could go back in time and go talk to younger Lisa, I would say ‘Run!’”


    Lisa Schmidt, TMJ patient

    Schmidt, 52, of Poway, California, said she was diagnosed with TMJ disorder in 2000 due to headaches, and an orthodontist immediately recommended her for a splint, braces, and surgery.

    After wearing the splint for only three days, Schmidt said, she was in “excruciating pain” and could no longer open her mouth far enough to eat solid food. Schmidt said she spent the next 17 years stuck on a “surgery carousel” with no escape, and eventually was in so much pain she abandoned her career as an aerospace scientist who worked alongside NASA astronauts.

    Schmidt said her low point came in 2016. In an attempt to restore bone that had been cut away in prior surgeries, a surgeon implanted long screws into Schmidt’s jaw that protruded downward out of her neck. Schmidt said she was instructed to tighten those screws with a screwdriver daily for about 20 days, lengthening the corners of her jaw to restore the bone that had been lost. It didn’t work, Schmidt said, and she was left in more pain than ever.

    “Every time you have a surgery, your pain gets worse,” Schmidt said. “If I could go back in time and go talk to younger Lisa, I would say ‘Run!’”

    Lack of sufficient evidence

    Many of the shortcomings of TMJ care were laid bare in the 426-page report published by the national academies in March 2020 that received limited public attention amid the coronavirus pandemic. The report’s 18 authors include medical and dental experts from Harvard, Duke, Clemson, Michigan State, and Johns Hopkins universities.

    Sean Mackey, a Stanford professor who co-led the team, said it found that patients were often steered toward costly treatments and “pathways of futility” instead of being taught to manage their pain through strategies and therapies with “good evidence.”

    “We learned it’s a quagmire,” Mackey said. “There is a perverse incentive in our society that pays more for things we do to people than [for] talking and listening to people. … Some of those procedures, some of those surgeries, clearly are not helping people.”

    Among its many findings, the national academies said it has been widely assumed in the field of dentistry that TMJ disorders are caused by a misaligned bite, so treatments have focused on patients’ teeth and bite for more than 50 years. But there is a “notable absence of sufficient evidence” that a misaligned bite is a cause of TMJ disorders, and the belief traces back to “inadequate research” in the 1960s that has been repeated in “poorly-designed studies” ever since, the report states.

    Therefore, TMJ treatment that makes permanent changes to the bite — like installing braces or crowns or grinding teeth down — has “no supporting evidence,” according to the national academies report. The NIH warns that these TMJ treatments “don’t work and may make the problem worse.”

    Dental splints, the most common TMJ treatment, also known as night guards or mouth guards, are removable dental appliances that are molded to fit over the teeth and can cost hundreds or even thousands of dollars out-of-pocket, according to the TMJ Association. Like most medical devices, splints generally go through the FDA’s 510(k) clearance process, which does not require each splint to be proven effective before it can be sold, according to the agency.

    The national academies’ report states that splints produce “mixed results” for TMJ patients, and even when splints succeed at reducing jaw pain it is not understood why they work. Hundreds of splint designs exist, the report states, and some dentists reject research that challenges the use of splints unless it focuses on the specific design they prefer.

    “Because of the hundreds of variations in [splint] design, it is unlikely that any study could ever be conducted that will be considered sufficient to a particular dentist with a pre-existing belief about the effectiveness of one appliance,” the report states.

    Other treatments fare no better. The FDA has not labeled any drugs specifically for TMJ disorders, and pain medicines can be too weak or addictive to be a long-term solution, according to the TMJ Association. Botox injections may ease pain but have raised concerns about bone loss during animal testing. The NIH warns that minor surgeries that flush the jaw with liquid bring only temporary pain relief and that more complex surgeries should be reserved for severe cases because they have yet to be proved safe or effective in the long term.

    To improve care, the national academies called for better education about TMJ disorders across medicine and dentistry and more research funding from the NIH, which has a “ripple effect” on research and training across the nation.

    Since the 2020 report, the NIH has launched a TMJ research collaborative and increased annual research funding from about $15 million to about $34 million, D’Souza said. TMJ care was added to the standards that dental schools must teach to be accredited in 2022. The national academies launched an ongoing forum on TMJ disorders last year.

    But TMJ funding still pales in comparison to other ailments. The NIH spends billions each year to research deadly diseases, like cancer and heart disease, that also afflict large numbers of Americans. It spends millions more on research of non-life-threatening conditions like arthritis, back pain, eczema, and headaches.

    Mackey noted that much of the NIH’s spending is allocated by Congress.

    “If Congress comes in and says, ‘We want to devote X amount of money to [TMJ],’ all of the sudden you will see an increase in money,” Mackey said. “So that’s my message to people out there: Raise your voices. Write your legislator.”

    Total jaw replacements

    Plagued by TMJ symptoms, and after failed treatments, some patients turn to a last resort: replacing their jaw joint with synthetic implants. Surgeons might replace the cartilage disk at the core of the joint or use “total joint replacement surgery” to fasten a metal hinge to the bones of the skull.

    But the implants have a harrowing history: Several disk implants were recalled or discontinued in the ’90s due to dangerous failures. The FDA now classifies TMJ implants among its most closely monitored medical devices because the products on the market today can cause “adverse health consequences” if the devices fail, according to the agency’s website.

    Two companies, Zimmer Biomet and Stryker, make the only total jaw replacement implants currently sold in the U.S.

    Zimmer Biomet, which has made its implant for more than two decades, described it in email statements as “a safe and efficacious solution” for patients who need their jaw joint replaced, either due to TMJ disorders, failed surgeries, injuries, or other ailments. An FDA-mandated study completed in 2017 found about 14% of patients who get the Zimmer Biomet implant require additional surgery or removal within 10 years, said agency spokesperson Carly Pflaum.

    Stryker, which in 2021 bought a company that made a total jaw replacement implant and now makes the implant itself, declined to comment. Although the NIH has advised TMJ patients to avoid surgery since at least 2022, Stryker launched a “patient-facing website” for the implant last year and is recruiting surgeons to be added to a “surgeon locator” feature on the site, according to posts on Facebook and LinkedIn.

    A study of the Stryker implant’s success rate was mandated by the FDA and completed in 2020, but the agency has yet to make the results public.

    D’Souza, the NIH official, said that based on her professional experience, she estimates that most total jaw replacement surgeries are ultimately ineffective.

    “The success rate is low,” D’Souza said. “It is not very encouraging.”

    Multiple patients provided KFF Health News and CBS News with medical records showing their total jaw replacement implants had to be removed due to malfunction, infection, or previously unknown metal allergies. Several patients said that since their implants were removed months or years ago, they have lived with no hinge in their jaw at all.

    Kalinowski, the TMJ patient in Maine, has had portions of her jaw joint replaced six times, including receiving four implants. Her medical records show that the cartilage disk on her right side was replaced in 1986 with an implant that was later recalled and again in 1987 with another that was later discontinued. Her left and right disks were replaced in 1992 with a muscle flap and rib graft, respectively, and her entire right joint was replaced with yet another implant that was later discontinued in 1998. Both joints were replaced again in 2015, her records show.

    Since then, Kalinowski said, her artificial jaw has functioned properly, although she remains in pain and cannot move her jaw from side to side. Her mouth hangs open when her face is at rest, and she drinks protein shakes for lunch because it’s easier than struggling with solid food.

    But the “worst part,” Kalinowski said, is that her surgeries caused nerve damage on her lower face, and so she has not felt her husband’s kisses since the ’90s.

    “If there was one moment in my life I could take back and do over again, it would be that first surgery. Because it set me on a trajectory,” Kalinowski said. “And it never goes away.”

    CBS News producer Nicole Keller contributed to this article.




    Kaiser Health NewsThis article was reprinted from khn.org, a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF – the independent source for health policy research, polling, and journalism.

    [ad_2]

    Source link

  • Inexpensive liquid works as well as dental sealants to keep tooth decay at bay

    Inexpensive liquid works as well as dental sealants to keep tooth decay at bay

    [ad_1]

    An inexpensive, cavity-fighting liquid called silver diamine fluoride (SDF) works as well as dental sealants to keep tooth decay at bay in a school cavity prevention and treatment program, according to a new study by researchers at NYU College of Dentistry. 

    The study, which followed more than 4,000 elementary school students for four years and is published in JAMA Pediatrics, shows that SDF is an effective alternative to sealants, and can increase access to dental care while reducing costs.

    Dental cavities are the most prevalent chronic disease in children and can lead to pain, school absences, and lower academic performance. To prevent cavities, especially among children less likely to see a dentist, the Centers for Disease Control and Prevention (CDC) supports the use of school sealant programs. In sealant programs, dental professionals visit schools to apply a thin, protective coating to the surface of teeth that hardens and safeguards against decay.

    SDF has emerged as another promising treatment for fighting cavities. Originally approved by the FDA for treating tooth sensitivity, the solution is brushed onto the surface of teeth, killing decay-causing bacteria and remineralizing teeth to prevent further decay.

    A growing body of research shows that SDF-;which is quicker to apply and less expensive than sealants-;can prevent and arrest cavities, reducing the need for drilling and filling.”


    Richard Niederman, DMD, professor of epidemiology & health promotion at NYU College of Dentistry and study’s senior author

    SDF in schools

    Researchers at NYU College of Dentistry led CariedAway, the nation’s largest school-based cavity prevention study, to compare the use of SDF and traditional sealants. The study included approximately 4,100 children in New York City elementary schools; more than a quarter of kids had untreated cavities at the start of the study.

    At each school visit, a team of health professionals examined children’s teeth and applied either sealants or SDF followed by fluoride varnish, depending on which treatment the school was randomly assigned to receive. Sealants were administered by dental hygienists, while SDF was applied by either dental hygienists or registered nurses, all under the supervision of a dentist. Starting in 2018, the team visited each school twice a year, although the COVID-19 pandemic and school closures led to missed visits.

    The researchers reported last year in the journal JAMA Network Open that a single treatment of either SDF or sealants prevented 80% of cavities and kept 50% of existing cavities from worsening two years later. The team continued their study for another two years, and in their study published in JAMA Pediatrics, found that SDF and sealants prevented roughly the same number of cavities after children were followed for a total of four years. Moreover, both sealants and SDF reduced the risk of decay at each follow-up visit.

    “Our longitudinal study reaffirms that both sealants and SDF are effective against cavities. SDF is a promising alternative that can support school-based cavity prevention-;not to replace the dental sealant model, but as another option that also prevents and arrests decay,” said Ryan Richard Ruff, PhD, MPH, associate professor of epidemiology & health promotion at NYU College of Dentistry and the study’s first author.

    “Most research shows that SDF can stop a cavity from progressing further. Our study demonstrated that SDF can prevent cavities from happening in the first place,” said Tamarinda Barry Godín, DDS, MPH, associate program director and supervising dentist for CariedAway, research scientist at NYU College of Dentistry, and the study’s coauthor. 

    An “untapped” oral health workforce

    Embracing SDF for cavity prevention and treatment in schools could keep kids from needing fillings, saving families and the healthcare system money. Yet these programs can only succeed if there are enough health professionals to provide care.

    The NYU researchers found that children who had SDF applied by dental hygienists and registered nurses had similar outcomes, suggesting that nurses-;including school nurses-;could play a crucial role in cavity prevention programs. 

    “Nurses may be an untapped resource for addressing oral health inequities,” added Ruff. “Our results suggest that nurses can effectively provide this preventive care, which could dramatically improve access, given the role of school nurses and the size of the nursing workforce.”

    This research was funded by the Patient-Centered Outcomes Research Institute (PCS-160936724). The CariedAway cavity prevention model is currently being used in three New Hampshire school districts, supported by Northeast Delta Dental. 

    Source:

    Journal reference:

    Ruff, R. R., et al. (2024). Noninferiority of Silver Diamine Fluoride vs Sealants for Reducing Dental Caries Prevalence and Incidence: A Randomized Clinical Trial. JAMA Pediatrics. doi.org/10.1001/jamapediatrics.2023.6770.

    [ad_2]

    Source link

  • Breakthrough $20 million OCT project aims to revolutionize eye health screening

    Breakthrough $20 million OCT project aims to revolutionize eye health screening

    [ad_1]

    In the United States, more than one-fourth of adults over age 40 have an eye disease, including glaucoma, cataracts or age-related macular degeneration, or a chronic health condition that affects the eyes, such as diabetic retinopathy. These conditions are a strain on an individual’s health as well as on the health-care system, yet early diagnosis and management can help to prevent more than 90% of severe vision loss.

    Chao Zhou, a professor of biomedical engineering in the McKelvey School of Engineering at Washington University in St. Louis, has been working to improve optical coherence tomography (OCT) systems that can conduct high-resolution imaging of the eyes. Now, with an up to $20 million contract from the Advanced Research Projects Agency for Health (ARPA-H), he plans to create a portable OCT system based on photonic integrated circuits (PIC) and custom-designed electronic integrated circuits that could offer advanced eye screening to many more patients and at a lower cost. The technology also could be used in other applications, such as cardiology, dermatology, dentistry, endoscopy and urology.

    The contract is part of ARPA-H’s first call for proposals for unconventional approaches to improving health outcomes across patient populations, communities, diseases and health conditions through breakthrough research and technological advancements. It is the first ARPA-H contract awarded to Washington University.

    Traditional OCT systems are expensive, complex, bulky and labor-intensive to assemble and calibrate. The proposed system would weigh a few pounds, take high-resolution 3D scans of the retina in less than a second and be a fraction of the cost of the traditional systems.

    The integration of photonic and electronic integrated circuits simplifies the assembly process and lowers production costs, making OCT more accessible to a wider range of health-care facilities and patients. Integrating components on a photonic chip also enhances overall stability and robustness, making these systems less susceptible to environmental influences and wear and tear, ensuring a longer lifespan and lower maintenance costs.”


    Chao Zhou, professor of biomedical engineering, McKelvey School of Engineering, Washington University in St. Louis

    Zhou’s group invented the space-division multiplexing optical coherence tomography (SDM-OCT), a technique that takes multiple high-definition OCT images simultaneously with a single detector and is at least 10 times faster than existing OCT scanners, which creates fewer opportunities for errors from patient movement. However, these systems required extensive time and labor to assemble components for each channel, which limited their broad use.

    With the ARPA-H funding, Zhou and collaborators will assemble the components in a photonic chip using advancements in complementary metal-oxide-semiconductor (CMOS) processes used in the semiconductor industry. This will streamline manufacturing and lower costs. Once functioning, they will conduct studies using the device on adult and pediatric patients.

    Developing a fully integrated photonic-integrated chip (PIC)-OCT system is very impactful yet also very challenging, the researchers said, so the team has divided its work into eight parts, ranging from developing components to testing. At the end of the five-year project, the team expects to have developed photonic and electronic chips and portable PIC-OCT prototypes specifically for ophthalmic imaging.

    The proposed system is more than 50 times faster than existing state-of-the-art commercial OCT systems at a fraction of the cost, the researchers said. By optimizing and integrating the photonic and electronic circuits, the researchers can create an integrated image acquisition and signal processing engine with benefits that extend into other areas of health care, such as glucose sensing and portable skin imagers.

    Collaborating with Zhou are:

    • Shu-Wei Huang, an assistant professor of electrical, computer and energy engineering and of biomedical engineering at the University of Colorado Boulder;
    • Aravind Nagulu, an assistant professor of electrical and systems engineering at the McKelvey School of Engineering;
    • Rithwick Rajagopal, MD, PhD, an associate professor of ophthalmology and visual sciences at Washington University School of Medicine;
    • Margaret Reynolds, MD, an assistant professor of ophthalmology and visual sciences at Washington University School of Medicine; and
    • Lan Yang, the Edwin H. & Florence G. Skinner Professor of electrical and systems engineering at the McKelvey School of Engineering.

    Yang said it is in her long-term interest to transform knowledge in photonics research into technologies and tangible products with a far-reaching societal impact, with health-care applications at the top of her agenda.

    “I’m excited to be part of this multidisciplinary team that aims to develop a new OCT system with capabilities and features enabled by advancements in nanofabrication processes for optoelectronic devices driven by various industries, from telecommunication to data centers and consumer electronics,” Yang said. “Our proposed portable OCT system, based on photonic integrated circuits (PIC), will provide advanced and cost-effective eye screening and extend its benefits to other medical fields.”

    Rajagopal said that eye doctors have benefitted from the diagnostic insights offered by OCT technology for the past 15 years, but the systems are limited by scan-speed and field-of-view.

    Most modern scanners can only image the very center of the retina -; the macula -; and require cooperative patients who have the mobility to maneuver into and stay steady on a desktop system for at least 30-60 seconds (or more), Rajagopal said.

    “I am enthusiastic about the potential clinical benefits offered by Dr. Zhou’s new system, as it may allow us to perform much higher-resolution scans and include simultaneous peripheral scanning in addition to the retinal center, all while taking a fraction of the time required by currently available systems,” Rajagopal said. “We may therefore be able to scan patients who are unable to cooperate for traditional ocular imaging, including young children and adults with disabilities, without the need for pupillary dilation or sedated exams.”

    The team will work with commercial foundries to fabricate the photonic and electronic integrated circuits.

    “Not only does this fully integrated PIC-OCT system outperform conventional OCT systems, but it also boasts excellent manufacturability and robustness and reduces device footprint,” Zhou said. “In addition, mass production would significantly reduce manufacturing costs, paving the way for widespread future dissemination.”

    While the team already has several U.S. and international patents related to the SDM-OCT, it is working with Washington University’s Office of Technology Management on patent applications for the improved design. They will also work with ARPA-H Project Accelerator Transition Innovation Office and with the Food & Drug Administration on regulatory considerations to clear the pathway for future clinical translation.

    “I am very excited to be part of this world-class team to pursue this ambitious project that makes OCT a true point-of-care solution,” Huang said. “It is a perfect example showing how PIC technology can be transformative in areas other than communication and computing.”

    [ad_2]

    Source link

  • Combined approach needed to address oral health inequalities and systemic health burden

    Combined approach needed to address oral health inequalities and systemic health burden

    [ad_1]

    ‘Time to put your money where your mouth is: addressing inequalities in oral health’ is the new Economist Impact white paper published today, commissioned by the EFP (European Federation of Periodontology) with support from Haleon. The paper explores the escalating burden of periodontitis and caries, highlighting the critical associations between these two diseases, and proposing a combined approach to level up the population’s oral and systemic health outcomes.

    A new caries prevention and care cost calculator is introduced in the paper, revealing direct treatment costs of US$357 billion yearly, which represents 4.9% of global health expenditure. Productivity losses due to caries, severe periodontitis, and severe tooth loss amount to an estimated $188 billion annually.

    The calculator, which estimates the long-term direct costs associated with managing dental caries between the ages of 12 and 65 years in six countries (Brazil, France, Germany, Italy, Indonesia, and the UK), also revealed:

    • The overall direct costs of caries varied from $10,284 billion in Italy to $36,231 billion in Brazil, partly due to differences in population sizes.
    • The largest per-person costs were estimated in the UK ($22,910) and were lowest in Indonesia ($7,414).
    • The direct costs of caries were highest in the most deprived group across all countries except Indonesia and Germany, where it was highest in the least deprived, followed closely by the most deprived.

    Oral diseases impact nearly half the world’s population, surpassing the burden of most common non-communicable diseases (NCDs). With dental caries affecting more than two billion people globally and severe gum disease ranking second with over one billion cases, this paper emphasizes the pressing need for action. By targeting common risk factors such as diet, tobacco, and alcohol use, it unveils a transformative opportunity to mitigate not only oral diseases but also those NCDs like diabetes, heart disease, cancer, and stroke that are linked to oral disease.

    Report initiator and contributor Professor Nicola West, EFP secretary general, said: “Time to put your money where your mouth is: addressing inequalities in oral health” is a timely reminder that there is no overall health without oral health. Oral diseases have surpassed all other non-communicable diseases in global prevalence, and for the majority of people, gum disease and tooth decay are totally preventable. Through this paper, the EFP is calling on policy makers and budget holders to put their money where their mouth is”, highlights Professor West.

    Building on the success of a previous Economist white paper on the cost of gum disease, “Time to take gum disease seriously”, which demonstrated the positive return on investment achieved through home-based preventive care and early diagnosis, the new white paper also introduces a conceptual framework detailing the progression of caries, spanning from a healthy tooth to an unsalvageable carious state. This innovative model outlines preventive interventions, such as maintaining oral hygiene by brushing with fluoridated toothpaste, applying topical fluoride and strategically targeting different stages to hinder or prevent caries development.

    As a global leader in consumer health, Haleon’s purpose is to deliver better everyday health with humanity. We are proud to have supported this initiative from both the EFP and Economist Impact Unit. It represents a further important step to better understand and raise awareness of the importance of Oral Health Promotion and Prevention, to help support the WHO action plans on oral health.”


    Steve Mason, Global Medical Lead for Oral Health at Haleon

    To encourage better oral health globally, it’s time to take decisive action. The paper showcases the need for stakeholders to invest and collectively champion preventive measures, promoting a better alignment between policy, public health, payment systems, and clinical practice.

    [ad_2]

    Source link

  • UT Health San Antonio School of Dentistry opens special-care dental clinic in South Texas

    UT Health San Antonio School of Dentistry opens special-care dental clinic in South Texas

    [ad_1]

    The UT Health San Antonio School of Dentistry has opened a special-care dental clinic, the first of its kind in an academic setting in South Texas that will serve people of all ages with intellectual, developmental, cognitive or physical disabilities.

    With spacious, specially designed treatment rooms featuring adjustable sound and lighting and even a “Zen Den” multi-sensory room to help reduce anxiety, the Phil and Karen Hunke Special Care Clinic occupies approximately 4,300 square feet on the first floor of the school’s Center for Oral Health Care and Research, at 8210 Floyd Curl Drive. The clinic is named for San Antonio-area philanthropists who provided seed money for the project. Phil Hunke, DDS, is a retired pediatric dentist.

    The state-of-the-art space includes seven dental treatment rooms and five rooms equipped with the capability to deliver conscious sedation, all to accommodate those with special needs and provide services for up to 40 patients per day. The clinic will serve the community and provide training for students.

    Numerous barriers exist in the current oral health care delivery model for individuals with special needs. At the heart of the issue is a lack of workforce trained and willing in the provision of services for this population.”


    Jennifer Farrell, DDS, DABSCSD, inaugural director of the clinic

    In one study, only 10% of dentists responding to a survey reported treating individuals with special needs and only one in four students had hands-on experience with those patients while in dental school.

    “Dental education institutions are the vital link in building a clinician base that will deliver services to this significantly underserved population,” said Peter M. Loomer, DDS, PhD, MBA, dean of the UT Health San Antonio School of Dentistry.

    Serving vital roles

    The clinic serves three vital roles. In addition to seeing patients from throughout South Texas, the facility will provide academic and clinical training to students in special-care dentistry across several disciplines, including dental and dental hygiene, medical, physician assistant and nursing. The clinic will serve as a resource for community dentists and social service providers, not only as a referral source but also for dissemination of information and advances in the treatment of individuals with special needs.

    The clinic builds on the region’s most comprehensive integrated dental practice, where patients receive care from experienced dentists, renowned specialists, advanced graduate residents or dental students overseen by faculty of the state’s top-ranked dental school.

    In addition to the generous support provided by the namesake donors, a $2 million federal Health Resources and Services Administration grant over five years is funding personnel and operating costs, and provider education. Also, $2.3 million from the Oral Health Improvement Program (OHIP) of the Texas Department of State Health Services is supporting the goal of expanding oral care for those with special health care needs.

    The roomy treatment areas allow multiple points of access based on the management needs of the patients, and with ample room for the patients and their families or caregivers, while being private. The Zen Den and a bubble wall offer sensory-regulating features.

    Entrances, the reception area and corridors also are designed to allow easy access, and with hallways that include railing and wheelchair bumpers. Patients will have access to a wheelchair tilt if needed, though most patients will be able to receive treatment in their wheelchairs without a tilt.

    Compehensive exams will determine what level of sedation is most appropriate for a patient, with five suites specially designed with the latest equipment to deliver full treatment along with conscious sedation. The clinic’s location inside the Center for Oral Health Care and Research gives access to additional treatment spaces that allow full sedation if necessary.

    “We provide a full range of preventive, routine and comprehensive dental care for all ages and dental needs,” said Micaela Gibbs, DDS, MHA, clinical associate professor and chief dental officer of the UT Health San Antonio School of Dentistry. “Customized care plans are created based on a patient’s unique set of circumstances and tolerance for treatments.”

    What to expect

    The first visit typically will include a comprehensive oral evaluation, X-rays, cleaning, fluoride application, tailored instructions for home oral hygiene care and nutritional guidance, and development of a tentative plan for ongoing care – and will take from one to two hours.

    The clinic accepts Medicaid for qualified patients under the age of 21 and select dental insurance. Third-party financing options are available for patients requiring a payment plan.

    As the clinic’s founding director, Farrell brings more than 30 years of experience providing care for patients with disabilities. Before joining here, she was director of the Special Patient Care Dental Program at Advocate Illinois Masonic Medical Center in Chicago for 13 years and treated patients with special needs through that program for more than 28 years.

    In 2021, Farrell received the Lawrence J. Chasko Distinguished Service Award from the Special Care Dentistry Association.

    [ad_2]

    Source link

  • New guidelines set safer standards for dental pain relief

    New guidelines set safer standards for dental pain relief

    [ad_1]

    Nonsteroidal anti-inflammatory drugs (NSAIDs) taken alone or along with acetaminophen are recommended as first-line treatments for managing short-term dental pain in adults and adolescents aged 12 or older, according to a new clinical practice guideline developed by the American Dental Association (ADA), the University of Pittsburgh School of Dental Medicine and the Center for Integrative Global Oral Health at the University of Pennsylvania School of Dental Medicine. The guideline has been endorsed by the ADA and is now available in the February issue of The Journal of the American Dental Association.

    Based on review of the available evidence, a guideline panel concluded that, when used as directed, NSAIDs (like ibuprofen and naproxen) alone or in combination with acetaminophen can effectively manage pain after having a tooth removed or when experiencing a toothache when dental care is not immediately available.

    The guideline also offers clinicians recommendations for prescribing opioid medications in the limited circumstances in which they may be appropriate. These include avoiding “just in case” prescriptions, engaging patients in shared decision-making and exerting extreme caution when prescribing opioids to adolescents and young adults. When prescribing opioids, the guideline suggests advising patients on proper storage and disposal and considering any risk factors for opioid misuse and serious adverse events.

    It’s important to take special consideration when prescribing any type of pain reliever, and now, dentists have a set of evidence-based recommendations to determine the best care for their patients. Patients are encouraged to discuss pain management expectations and strategies with their dentist so they can feel confident that they are receiving the safest, most effective treatment for their symptoms.”


    Dr. Paul Moore, D.M.D., Ph.D., M.P.H., the guideline’s senior author and panel chair and professor emeritus at the University of Pittsburgh’s School of Dental Medicine

    In 2020, the U.S. Food and Drug Administration (FDA) awarded the University of Pittsburgh and the ADA Science & Research Institute (ADASRI) – now the ADA Forsyth Institute – a three-year $1.5 million grant to develop a clinical practice guideline for the management of acute pain in dentistry in children, adolescents and adults. A group of researchers and methodologists from ADASRI, University of Pittsburgh School of Dental Medicine, Center for Integrative Global Oral Health at the University of Pennsylvania School of Dental Medicine, McMaster University and The Art of Democracy worked together to develop the guideline.

    “Providing prescribing guidelines for acute dental pain management is an important step towards improving patient treatment and outcomes,” said Dr. Marta Sokolowska, Ph.D., deputy center director for substance use and behavioral health at the FDA’s Center for Drug Evaluation and Research. “We hope this clinical practice guideline will reduce the risk of opioid addiction, overdose and diversion.”

    This is the second of two guidelines on acute dental pain management. A previous set of recommendations for pediatric patients was published in 2023. Both guidelines can be found at ada.org/painmanagement.

    Source:

    Journal reference:

    Carrasco-Labra, A., et al. (2024). Evidence-based clinical practice guideline for the pharmacologic management of acute dental pain in adolescents, adults, and older adults. The Journal of the American Dental Association. doi.org/10.1016/j.adaj.2023.10.009.

    [ad_2]

    Source link